
Ilia I. Ouspenski
Examiner (ID: 1237)
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1566 |
| Issued Applications | 1023 |
| Pending Applications | 156 |
| Abandoned Applications | 432 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12112979
[patent_doc_number] => 09868961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-16
[patent_title] => 'Methods and compositions for localized secretion of anti-CTLA-4 antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/294889
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10917
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12294889
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/294889 | Methods and compositions for localized secretion of anti-CTLA-4 antibodies | Mar 29, 2007 | Issued |
Array
(
[id] => 5246960
[patent_doc_number] => 20070243194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Anti-IGF-1R antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/727887
[patent_app_country] => US
[patent_app_date] => 2007-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 89795
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243194.pdf
[firstpage_image] =>[orig_patent_app_number] => 11727887
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/727887 | Anti-IGF-1R antibodies and uses thereof | Mar 27, 2007 | Issued |
Array
(
[id] => 6220625
[patent_doc_number] => 20100055720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'USE OF THE 4-lBB RECEPTOR FOR IDENTIFYING AND/OR SEPARATING ACTIVATED REGULATORY TH CELLS (TREG)'
[patent_app_type] => utility
[patent_app_number] => 12/294181
[patent_app_country] => US
[patent_app_date] => 2007-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9159
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055720.pdf
[firstpage_image] =>[orig_patent_app_number] => 12294181
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/294181 | Use of the 4-1BB receptor for identifying and/or separating activated regulatory Th cells (Treg) | Mar 25, 2007 | Issued |
Array
(
[id] => 5415882
[patent_doc_number] => 20090041769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Methods of treatment using CTLA4 mutant molecules'
[patent_app_type] => utility
[patent_app_number] => 11/725762
[patent_app_country] => US
[patent_app_date] => 2007-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13676
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041769.pdf
[firstpage_image] =>[orig_patent_app_number] => 11725762
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/725762 | Methods of treatment using CTLA4 mutant molecules | Mar 19, 2007 | Issued |
Array
(
[id] => 4687695
[patent_doc_number] => 20080031876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'CTLA4 molecules and IL4-binding molecules and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/725384
[patent_app_country] => US
[patent_app_date] => 2007-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 22467
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20080031876.pdf
[firstpage_image] =>[orig_patent_app_number] => 11725384
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/725384 | Soluble CTLA4 mutant molecules | Mar 18, 2007 | Issued |
Array
(
[id] => 5258732
[patent_doc_number] => 20070212364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'METHODS FOR DECREASING THE TOXIC EFFECTS OF NICOTINE ON FETUSES IN PREGNANT WOMEN'
[patent_app_type] => utility
[patent_app_number] => 11/679022
[patent_app_country] => US
[patent_app_date] => 2007-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4627
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212364.pdf
[firstpage_image] =>[orig_patent_app_number] => 11679022
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/679022 | Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women | Feb 25, 2007 | Issued |
Array
(
[id] => 4771408
[patent_doc_number] => 20080057066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'METHODS AND COMPOSITIONS FOR TARGETING RELT'
[patent_app_type] => utility
[patent_app_number] => 11/674074
[patent_app_country] => US
[patent_app_date] => 2007-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 40659
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057066.pdf
[firstpage_image] =>[orig_patent_app_number] => 11674074
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/674074 | METHODS AND COMPOSITIONS FOR TARGETING RELT | Feb 11, 2007 | Abandoned |
Array
(
[id] => 4988129
[patent_doc_number] => 20070154468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Use of CD28-specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections'
[patent_app_type] => utility
[patent_app_number] => 11/702560
[patent_app_country] => US
[patent_app_date] => 2007-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7531
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20070154468.pdf
[firstpage_image] =>[orig_patent_app_number] => 11702560
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/702560 | Use of CD28-specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections | Feb 5, 2007 | Abandoned |
Array
(
[id] => 1077095
[patent_doc_number] => 07615611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-10
[patent_title] => 'Human cytokine receptor'
[patent_app_type] => utility
[patent_app_number] => 11/670074
[patent_app_country] => US
[patent_app_date] => 2007-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61353
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/615/07615611.pdf
[firstpage_image] =>[orig_patent_app_number] => 11670074
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/670074 | Human cytokine receptor | Jan 31, 2007 | Issued |
Array
(
[id] => 303439
[patent_doc_number] => 07534575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Method for detecting cancer using an antibody to Zcytor16'
[patent_app_type] => utility
[patent_app_number] => 11/670209
[patent_app_country] => US
[patent_app_date] => 2007-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61357
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534575.pdf
[firstpage_image] =>[orig_patent_app_number] => 11670209
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/670209 | Method for detecting cancer using an antibody to Zcytor16 | Jan 31, 2007 | Issued |
Array
(
[id] => 191033
[patent_doc_number] => 07642345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-05
[patent_title] => 'Polynucleotides encoding human cytokine receptor'
[patent_app_type] => utility
[patent_app_number] => 11/670147
[patent_app_country] => US
[patent_app_date] => 2007-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61361
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/642/07642345.pdf
[firstpage_image] =>[orig_patent_app_number] => 11670147
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/670147 | Polynucleotides encoding human cytokine receptor | Jan 31, 2007 | Issued |
Array
(
[id] => 4927450
[patent_doc_number] => 20080166813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Human OX2 receptors'
[patent_app_type] => utility
[patent_app_number] => 11/700630
[patent_app_country] => US
[patent_app_date] => 2007-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14405
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20080166813.pdf
[firstpage_image] =>[orig_patent_app_number] => 11700630
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/700630 | Human OX2 receptors | Jan 29, 2007 | Issued |
Array
(
[id] => 5219293
[patent_doc_number] => 20070160604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'METHODS OF IDENTIFYING COMPOUNDS CAPABLE OF MODULATING T CELL IMMUNE RESPONSES INVOLVING SEMA4A PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 11/668121
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9829
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160604.pdf
[firstpage_image] =>[orig_patent_app_number] => 11668121
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/668121 | METHODS OF IDENTIFYING COMPOUNDS CAPABLE OF MODULATING T CELL IMMUNE RESPONSES INVOLVING SEMA4A PROTEIN | Jan 28, 2007 | Abandoned |
Array
(
[id] => 3530
[patent_doc_number] => 07815904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-19
[patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent'
[patent_app_type] => utility
[patent_app_number] => 11/656322
[patent_app_country] => US
[patent_app_date] => 2007-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26179
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/815/07815904.pdf
[firstpage_image] =>[orig_patent_app_number] => 11656322
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/656322 | Method of treating a pathological syndrome and a pharmaceutical agent | Jan 21, 2007 | Issued |
Array
(
[id] => 4733381
[patent_doc_number] => 20080050360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent'
[patent_app_type] => utility
[patent_app_number] => 11/656218
[patent_app_country] => US
[patent_app_date] => 2007-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26155
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050360.pdf
[firstpage_image] =>[orig_patent_app_number] => 11656218
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/656218 | Method of treating a pathological syndrome and a pharmaceutical agent | Jan 21, 2007 | Abandoned |
Array
(
[id] => 4733413
[patent_doc_number] => 20080050392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent'
[patent_app_type] => utility
[patent_app_number] => 11/656217
[patent_app_country] => US
[patent_app_date] => 2007-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26153
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050392.pdf
[firstpage_image] =>[orig_patent_app_number] => 11656217
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/656217 | Method of treating hypertension disorder and a pharmaceutical agent | Jan 21, 2007 | Issued |
Array
(
[id] => 4733413
[patent_doc_number] => 20080050392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent'
[patent_app_type] => utility
[patent_app_number] => 11/656217
[patent_app_country] => US
[patent_app_date] => 2007-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26153
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20080050392.pdf
[firstpage_image] =>[orig_patent_app_number] => 11656217
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/656217 | Method of treating hypertension disorder and a pharmaceutical agent | Jan 21, 2007 | Issued |
Array
(
[id] => 4657124
[patent_doc_number] => 20080025985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent'
[patent_app_type] => utility
[patent_app_number] => 11/656225
[patent_app_country] => US
[patent_app_date] => 2007-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26176
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20080025985.pdf
[firstpage_image] =>[orig_patent_app_number] => 11656225
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/656225 | Method of treating a pathological syndrome and a pharmaceutical agent | Jan 21, 2007 | Abandoned |
Array
(
[id] => 5159851
[patent_doc_number] => 20070172895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'CD86 and CD80 receptor competition assays'
[patent_app_type] => utility
[patent_app_number] => 11/656206
[patent_app_country] => US
[patent_app_date] => 2007-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 8275
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172895.pdf
[firstpage_image] =>[orig_patent_app_number] => 11656206
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/656206 | CD86 and CD80 receptor competition assays | Jan 21, 2007 | Issued |
Array
(
[id] => 9026085
[patent_doc_number] => 08535664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-17
[patent_title] => 'Method of treating a pathological syndrome and a pharmaceutical agent'
[patent_app_type] => utility
[patent_app_number] => 11/656226
[patent_app_country] => US
[patent_app_date] => 2007-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26238
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11656226
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/656226 | Method of treating a pathological syndrome and a pharmaceutical agent | Jan 21, 2007 | Issued |